Scoping review protocol: bladder cancer in Nigeria: what are the gaps in clinical care and research?

Abstract

IntroductionBladder cancer (BC) is the 10th common cancer worldwide and ranks seventh in Nigeria. This scoping review aims to identify the gaps in clinical care and research of BC in Nigeria as part of the development of a larger national research programme aiming to improve outcomes and care of BC.Methods and analysisThis review will be conducted according to Arksey and O’Malley scoping review methodology framework. The following electronic databases will be searched: Medline (using the PubMed interface), Ovid Gateway (Embase and Ovid), Cochrane library and Open Grey literature. Two independent reviewers will screen titles and abstracts and subsequently screen full-text studies for inclusion, any lack of consensus will be discussed with a third reviewer. Any study providing insight into the epidemiology or treatment pathway of BC (RCTs, observations, case series, policy paper) will be included. A data chart will be used to extract relevant data from the included studies. Results will be reported according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for scoping reviews. A consultation process will be carried out with a multidisciplinary team of Nigerian healthcare professionals, patients and scientists.Ethics and disseminationThe results will be disseminated through peer-reviewed publications. By highlighting the key gaps in the literature, this review can provide direction for future research and clinical guidelines in Nigeria (and other low-income and middle-income countries), where BC is more prevalent due to local risk factors and healthcare settings.

Scoping review: bladder cancer in Nigeria – what are the gaps in clinical care and research?

“…Preferred Reporting Items for Systematic Reviews and Meta-Analyses-Scoping Reviews extension for scoping reviews 18 were followed to ensure all suggested items were reported. A detailed protocol of this scoping review has been published previously 19 and a brief summary is presented in figure 1.…”

Acoustic Droplet Printing Tumor Organoids for Modeling Bladder Tumor Immune Microenvironment within a Week

“…Patients with early superficial bladder cancer have a 5-year recurrence rate of 60% to 80%, while patients with muscle-invasive bladder cancer have a 5-year mortality rate of 65%. [1] Conventional treatments with advanced bladder cancer have many side effects, poor drug resistance, and limited efficacy, causing great pain to patients. [2][3][4] Therefore, there is an urgent need for a patientderived in vitro tumor model as a preclinical tool to guide personalized patient treatment.…”

The Importance of Patient and Public Involvement in Cancer Research: Time to Create a New Job Profile

“…A PPI coordinator has the essential role of bridging between researchers, patients and the public [7]. Our PPI coordinator has been supporting a wide variety of studies, especially those where discussion meetings are needed to inform the study design or those where a consultation phase is required as part of, for example, a scoping review [8,9]. Even though most cancer researchers recognize the importance of PPI/E, it is not always possible or easy to include it in their research strategy.…”